Bacterial And Fungal Causes Of Hemoptysis In Patients Of A Tertiary Care Center In Western Uttar Pradesh
Bacterial And Fungal Causes Of Hemoptysis
DOI:
https://doi.org/10.70284/njirm.v3i5.2096Keywords:
Hemoptysis, Tuberculosis, Etiology, Aspergillus, NeoplasmAbstract
Objective: To study the various bacterial, fungal and neoplastic causes of hemoptysis in patients of different age groups in a teaching hospital in western Uttar Pradesh (U.P) Materials & Methods: One hundred & Eighty patients who were admitted to the Department of Chest & T.B and in the Department of Medicine from Jan 2010 to Jan 2012 were included in this study. The patients were characterized on the basis of Clinical signs & symptoms, physical examination, complete blood count with platelets, bleeding time, clotting time, prothrombin time [clotting profile] chest radiography, CT scan, bronchoscopy, histopathological examination and microbial examination including culture of sputum & Bronchoalveolar Lavage. Results: Out of 180 patients admitted, 114 were males & 66 were females. The cause has been identified in 55 patients (32 males & 23 females) while in remaining cases the cause was undiscovered. Pulmonary tuberculosis was identified as the most leading cause of hemoptysis (38.16%) [Mycobacterium tuberculosis alone and M. tuberculosis with other bacteria in case of coinfection], followed by bacterial agents [Staphylococcus aureus (9.09%), Klebsiella spp (9.09%), Pseudomonas aeruginosa (5.45%) and Streptococcus pneumoniae (1.81%). Among the fungal agent we have found Aspergillus spp (10.9%) and Mucor in 1 case (1.81%). The other group of patients include the neoplasms (20.0%). Coinfection was seen among (14.54%) patients and the agents were [Mycobacterium tuberculosis & Pseudomonas aeruginosa] (5.45%), [M. tuberculosis & S. aureus] (3.63%), [M.tuberculosis & klebsiella spp] (1.81%), [Klebsiella & S.aureus] (3.63 %) Conclusion: In developing countries like India with such an increasing population, hemoptysis is one of the potentially life threatening symptom of underlying respiratory tract infection. An adequate & efficient evaluation of the etiological agents causing hemoptysis plays a pivotal role in management of such patients. The purpose of this study was to identify the different etiological agents along with the other causes of hemoptysis.
References
2. Turcios NL, Vega M. The child with hemoptysis. Hosp Pract 1987; 22: 217-218.
3. Thompson AB, Teschler H, Rennard SI. Pathogenesis, evaluation, and therapy for massive hemoptysis. Clin Chest Med. 1992;13:69–82.
4. Johnston H, Reisz G. Changing spectrum of hemoptysis: underlying causes in148 patients undergoing diagnostic flexible fiberoptic bronchoscopy. Arch Intern Med. 1989;149:1666-1668.5. Hirschberg B, Biran I, Glazer M, et al. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest. 1997;112:440-444.
6. Tom LW, Weisman RA, Handler SD. Hemoptysis in children. Ann Otol Rhinol Laryngol. 1980;89:419-424.
7. Fabian MC, Smitheringale A. Hemoptysis in children: the Hospital for Sick Children experience. J Otolaryngol. 1996;25:44-45.
8. Thompson JW, Nguyen CD, Lazar RH, et al. Evaluation and management of hemoptysis in infants and children: a report of nine cases. Ann Otol Rhinol Laryngol.1996;105:516-520.
9. Bidwell JL, Pachner RW. Hemoptysis: Diagnosis and management. Am Fam Physician. 2005;72:1253–60.
10. Rao PU. Hemoptysis as a symptom in a chest clinic. Indian J Chest Dis. 1960;2:219.
11. Ashraf O. Hemoptysis: A developing world perspective. BMC Pulmonary Med. 2006;6:1.
12. Abal AT, Nair PC, Cherjan J. Hemoptysis: Aetiology, evaluation and outcome-a prospective study in a third-world country. Respir Med. 2001;95:548–52.
13. Stebbings AE, Lim TK. Cause, treatment and outcome of patients with life-threatening hemoptysis. Singapore Med J. 1999;40:67–9.
14. Domoua K, N'Dhatz M, Coulibaly G, Aka-Danguy E, Traore F, et al. Hemoptysis:main etiologies observed in a pneumology department in Africa. Rev Pneumol Clin. 1994;50:59–62.
15. Reisz G, Stevens D, Boutwell C, Nair V. The causes of hemoptysis revisited. A review of the etiologies of hemoptysis between 1986 and 1995. Mo Med. 1997;94:633–5.
16. Johnston RN, Lockhart W, Ritchie RT, Smith DH. Hemoptysis. Br Med J. 1960;1:592–5.
17. Santiago S, Tobias J, Williams AJ. A reappraisal of the causes of hemoptysis. Arch Intern Med. 1991;151:2449–51.
18. Pursel SE, Lindskog GE. Hemoptysis: A clinical evaluation of 105 patients examined consecutively on a thoracic surgical service. Am Rev Respir Dis. 1961;84:329–36.
19. Van Kralingen KW, van Kralingen-Heijboer AC, Zimmerman M, Postmus PE. Management of hemoptysis in a Third World city hospital: a
retrospective study. Tuber Lung Dis. 1995;76:344–8.
20. Souders CR, Smith AT. The clinical significance of hemoptysis. N Engl J Med. 1952;247:790–4.
21. Moersch HJ. Clinical significance of Hemoptysis. JAMA. 1952;148:1461–5.
22. Baric D. The origin of hemoptysis in patients admitted to the pneuno-phtisiology department of the Zadar Hospital between 1970 and 1980. Bull IUAT. 1984;59:205–6.
23. Turcios NL, Vega M. The child with hemoptysis. Hosp Pract. 1987;22:214, 217-218.
